Treatment Patterns and Lipid Profile in Patients with Familial Hypercholesterolemia in Japan.
CONCLUSIONS: Treatment and management of LDL-C in Japanese FH patients remain suboptimal. The results suggest that FH is underdiagnosed in real-world, routine clinical practice in Japan. There is an urgent need to improve the diagnostic rate of FH and to provide the appropriate therapy to achieve the recommended LDL-C levels of <100 mg/dL or a more than 50% reduction for patients with FH in Japan.
PMID: 29353825 [PubMed - as supplied by publisher]
Source: Journal of Atherosclerosis and Thrombosis - Category: Cardiology Tags: J Atheroscler Thromb Source Type: research
More News: Cardiology | Cholesterol | Databases & Libraries | Electronic Medical Records (EMR) | Epidemiology | Japan Health | Statin Therapy | Study | Thrombosis